Vincristine therapy of idiopathic and secondary thrombocytopenias.
about
Defibrotide in recurrent thrombotic thrombocytopenic purpura.Management of thrombotic thrombocytopenic purpura.Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease.Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus.Splenectomy for thrombocytopenia associated with systemic lupus erythematosus in 11 Chinese patients.Management of immune thrombocytopenic purpura in children: potential role of novel agents.Treatment-refractory multi-lineage autoimmune cytopenia after unrelated cord blood transplantation: remission after combined bortezomib and vincristine treatment.Haematological manifestations of lupus.Vincristine efficacy and safety in treating immune thrombocytopenia: a retrospective study of 35 patients.Low-dose vincristine in the treatment of corticosteroid-refractory idiopathic thrombocytopenic purpura (ITP) in non-splenectomized patients.Thrombotic thrombocytopenic purpura plasma enhances platelet-leucocyte interaction in vitro.Anti-CD36 autoantibodies in thrombotic thrombocytopenic purpura and other thrombotic disorders: identification of an 85 kD form of CD36 as a target antigen.Miliary tuberculosis presenting with hyponatremia and thrombocytopenia.Report of an international symposium on narrowing the Gap in the treatment and study of SLE worldwide: minimum best practices in the management and monitoring of moderate to severe SLE and improving outcomes in constrained environmentsThe effects of colcemid on hematopoiesis in the mouse.Splenectomy in systemic lupus erythematosus and autoimmune hematologic disease: a comparative analysis.
P2860
Q33332186-235217B3-602E-4671-8E1D-CD552270CFEFQ33333063-40F83AD8-A9B0-42D7-8DC4-1771653B23B1Q33335807-D92B696B-DC31-4DA9-9AC8-C0335ECC3253Q33361803-7A145A5E-1B4F-42EE-9AF4-7C9F25BCB1ABQ33386932-6E293D48-6473-4EC2-B49A-01FDDB06F525Q33395863-08F1BE44-8CEE-4504-B6B4-21916A9FBD21Q33416169-6B781D86-8930-4A8B-A788-EF3A7DD0D092Q33421876-88317CC8-D05E-4A7F-AE0D-4FFC48ECB397Q33422846-3211747B-6206-439A-9061-B15FE3569D28Q33485361-CBF24A58-6A37-4B9B-8ABB-3A2B09BD4224Q33501513-3D80071F-8011-4DFB-B616-C4605ABA7B89Q33504686-28827521-CA8F-4E94-B0C1-EA184D372F11Q33505002-492DE4E9-CA69-47CB-A1F1-523D6B1DE329Q35680662-A99D713E-6289-4AB3-8F68-63CA264CD7D9Q35905235-2222A2C6-0786-4B73-80EA-E73678D2DA1AQ47559187-6C61FA9A-6571-4224-9620-5B918F385408
P2860
Vincristine therapy of idiopathic and secondary thrombocytopenias.
description
1974 nî lūn-bûn
@nan
1974 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1974 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1974年の論文
@ja
1974年論文
@yue
1974年論文
@zh-hant
1974年論文
@zh-hk
1974年論文
@zh-mo
1974年論文
@zh-tw
1974年论文
@wuu
name
Vincristine therapy of idiopathic and secondary thrombocytopenias.
@ast
Vincristine therapy of idiopathic and secondary thrombocytopenias.
@en
type
label
Vincristine therapy of idiopathic and secondary thrombocytopenias.
@ast
Vincristine therapy of idiopathic and secondary thrombocytopenias.
@en
prefLabel
Vincristine therapy of idiopathic and secondary thrombocytopenias.
@ast
Vincristine therapy of idiopathic and secondary thrombocytopenias.
@en
P2093
P1476
Vincristine therapy of idiopathic and secondary thrombocytopenias.
@en
P2093
P304
P356
10.1056/NEJM197408222910802
P407
P577
1974-08-01T00:00:00Z